鶹ý

Feature Channels: Heart Disease

Filters close
Go to Advanced Search
鶹ý: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified Coronary Artery Disease
Released: 31-Mar-2025 2:25 PM EDT
Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified Coronary Artery Disease
Mount Sinai Health System

Study led by Mount Sinai researcher could lead to more widespread use of imaging technique to improve survival and prevent complications

鶹ý: Electronic Provider Alerts Improve Treatment Rates of Valvular Heart Disease
Released: 30-Mar-2025 2:30 PM EDT
Electronic Provider Alerts Improve Treatment Rates of Valvular Heart Disease
University of California, San Francisco (UCSF)

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated. Researchers from UC San Francisco (UCSF) and Mass General Brigham found that electronic messages sent to providers within one week of patients receiving an echocardiogram improved care for patients with severe AS — including higher rates of treatment with aortic valve replacement (AVR), particularly in symptomatic patients.

鶹ý: Reduced Sodium Legislation Saves Lives
Released: 29-Mar-2025 1:30 PM EDT
Reduced Sodium Legislation Saves Lives
University of the Witwatersrand, Johannesburg

South Africa’s 2013 sodium reduction law is lowering blood pressure and improving health. A study by Wits & Harvard found a 10% drop in sodium intake, with stricter limits in processed foods. Even small reductions cut heart disease risk. Experts say more countries should follow suit. #PublicHealth

鶹ý: Monoclonal Antibody Can Reverse Effects of Bleeding and Complications Linked to Common Medication for Heart Attacks
Released: 29-Mar-2025 12:45 PM EDT
Monoclonal Antibody Can Reverse Effects of Bleeding and Complications Linked to Common Medication for Heart Attacks
Mount Sinai Health System

Trial led by Mount Sinai researcher could save lives for patients in need of urgent surgery, invasive procedures, or experiencing major bleeding

Released: 28-Mar-2025 5:50 PM EDT
MiRus Siegel™ TAVR: First EFS Cases
MiRus

MiRus is pleased to announce the launch of the US multi-center Early Feasibility Study of the Siegel™ 8-Fr aortic transcatheter heart valve (THV).

   
Released: 27-Mar-2025 8:20 AM EDT
NIH-Funded Trial Studies if Wearables Can Reduce the Need for Continuous Blood Thinners for Patients with Atrial Fibrillation
Northwestern Medicine

Atrial fibrillation (AFib) is the most common type of heart arrhythmia impacting more than 5 million people in the United States, a number that is anticipated to reach 12.1 million by 2030. The heart rhythm condition is characterized by fast and irregular heartbeats from the upper chambers of the heart. People with AFib are at increased risk of stroke, heart failure, dementia, and premature death.

Released: 26-Mar-2025 12:00 PM EDT
MiR-21-5p-enriched exosomes from hiPSC-derived cardiomyocytes exhibit superior cardiac repair efficacy compared to hiPSC-derived exosomes in a murine MI model
World Journal of Stem Cells

BACKGROUNDHeart disease remains a leading cause of mortality worldwide, with existing treatments often failing to effectively restore damaged myocardium. Human-induced pluripotent stem cells (hiPSCs) and their derivatives offer promising th

鶹ý: 1920_cedars-sinai-smidt-heart-institute.jpg?10000
Released: 26-Mar-2025 5:05 AM EDT
Preclinical Study: After Heart Attack, a Boost in Anti-Inflammatory Cells Promoted Healing
Cedars-Sinai

A scientific technique that rapidly increases the body’s production of anti-inflammatory cells promoted healing from heart attacks in mice, according to a new study by investigators from the Smidt Heart Institute at Cedars-Sinai.

鶹ý: 1920_raj-makkar-md-cedars-sinai-smidt-heart-institute-2.jpg?10000
Released: 25-Mar-2025 7:50 PM EDT
ACC.25: Smidt Heart Institute Experts Present Late-Breaking Research
Cedars-Sinai

Physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will present research and be honored for their ongoing work in cardiovascular research and care during the American College of Cardiology’s Annual Scientific Session taking place March 29-31 in Chicago.

Released: 25-Mar-2025 7:45 PM EDT
Transforming Cardiovascular Care Through Upfront Combination Therapy
Ochsner Health

Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. “Chip” Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious Mayo Clinic Proceedings highlighting the comparative efficacy of lipid-lowering therapies for reducing cardiovascular risks and led by Maciej Banach, MD,PhD from Poland and leader of the International Lipid Expert Panel ( ILEP).

鶹ý: Study Implicates 60 Genes in Congenital Heart Disease, Including Some That That Also Contribute to Related to Disorders Such as Autism
Released: 25-Mar-2025 5:40 PM EDT
Study Implicates 60 Genes in Congenital Heart Disease, Including Some That That Also Contribute to Related to Disorders Such as Autism
Rockefeller University

A surprising mix of inherited and de novo mutations in 60 genes contribute to 10 percent of CHD cases. Many of these same mutations also contribute to neurodevelopmental disorders including autism. 

Released: 24-Mar-2025 6:10 PM EDT
New Study Reveals How Polluting Industries and Healthcare Disparities Drive Congenital Heart Defect Rates in Mexico
George Washington University

A one of its kind study has uncovered the significant role that environmental pollution and healthcare disparities play in the prevalence of congenital heart defects in Mexico.

Not for public release

This news release is embargoed until 24-Mar-2025 5:00 PM EDT Released to reporters: 18-Mar-2025 8:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Mar-2025 5:00 PM EDT The 鶹ý PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

鶹ý: University Hospitals Harrington Heart & Vascular Institute at UH Portage Medical Center Study Shows Improved Patient Cardiovascular Outcomes
Released: 24-Mar-2025 10:45 AM EDT
University Hospitals Harrington Heart & Vascular Institute at UH Portage Medical Center Study Shows Improved Patient Cardiovascular Outcomes
University Hospitals Cleveland Medical Center

University Hospitals Harrington Heart & Vascular Institute at UH Portage Medical Center announces a significant reduction in cardiovascular mortality trends since a $2.5 million dollar investment to establish a local catheterization lab and preventive screening programs.

Released: 20-Mar-2025 7:35 PM EDT
Registration for TCT 2025 Now Open
Cardiovascular Research Foundation (CRF)

The Cardiovascular Research Foundation (CRF) is pleased to announce that registration is now open for TCT 2025 (Transcatheter Cardiovascular Therapeutics®), the world’s premier educational symposium in interventional cardiovascular medicine. TCT 2025 will take place October 25-28, 2025, at the Moscone Center in San Francisco, California.

鶹ý: How a Y Chromosome Gene May Shape the Course of Heart Valve Disease
Released: 20-Mar-2025 5:20 AM EDT
How a Y Chromosome Gene May Shape the Course of Heart Valve Disease
University of California San Diego

Researchers have shed new light on how a type of heart valve disease—aortic valve stenosis—progresses differently in males and females. The research paves the way for treatments that can be tailored to a patient's biological sex.

Released: 18-Mar-2025 11:55 AM EDT
"Morí dos veces ese día": La superestrella del country-rap, Colt Ford, cuenta cómo sobrevivió a un infarto casi letal
Mayo Clinic

Las enfermedades cardíacas son la principal causa de muerte en el mundo. Uno de los tipos más comunes de enfermedades cardiovasculares es el infarto. Solo en Estados Unidos, se estima que cada 40 segundos, alguien sufre un infarto. Una de esas personas es el artista de música country-rap Colt Ford.

   
Released: 18-Mar-2025 10:05 AM EDT
"Eu morri duas vezes naquele dia": O superastro do country-rap, Colt Ford, conta como sobreviveu a um infarto quase letal
Mayo Clinic

As doenças cardíacas são a principal causa de morte no mundo. Um dos tipos mais comuns de doenças cardiovasculares é o infarto. Somente nos Estados Unidos, estima-se que a cada 40 segundos, alguém sofra um infarto. Uma dessas pessoas é o artista de música country-rap Colt Ford.

   


close
3.0485